HBV杂志回顾 Christine Kukka

StephenW

HBV Journal Review by Christine Kukka —In this month's column Chris reviews the following studies that will help you understand the complexities of hepatitis B:

• Study Finds Only 21% of Hepatitis B Patients Are Treated Correctly
  

• Combination of Chinese Herbs Plus Antiviral Entecavir Proves Effective
  

• Caesarians Reduce Infection of Newborns When Mothers Have High Viral Loads
  

• Combined Antiviral and Interferon Treatment Effective in Those Under Age 30
  

• New Tenofovir Formula May Lead to Less Bone Loss and Kidney Problems
  

• HBV Mutation Found Only in Men May Explain Their Higher Rates of Liver Damage
  

• Sumo Wrestlers Found to Transmit HBV Infection
  

• Taiwan's Hepatitis B Immunization of Infants Reduces Hepatitis B by 90%
  

• Tenofovir Reverses Severe, Decompensated Cirrhosis
  

•     研究发现，只有21％的乙肝患者正确对待
  
      中国中药加抗病毒药物恩替卡韦的组合证明有效
  
      对Caesarians当母亲有高病毒载量，减少新生儿感染
  
      结合抗病毒药物和干扰素治疗有效在那些30岁以下
  
      新泰诺福韦公式可能会导致较少骨质流失和肾脏问题
  
      HBV基因突变仅见于男性，也许可以解释其较高的价格肝损害
  
      相扑发现发送HBV感染
  
      台湾的B型肝炎的婴儿接种乙型肝炎减少90％
  
      泰诺福韦反转严重，肝硬化失代偿期
  

咬牙硬挺

楼主动作好快啊，佩服你这么久的坚持